Skip to the main content.


KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing

Offering extends legacy of SUREtechnology Platform™ for more efficient workflows and simplified processes. Durham, North Carolina (September 12, 2023) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of SUREmAb™,...

Read More

KBI Biopharma Continues to Strengthen Leadership and Expertise With Key Executive Appointments

Durham, North Carolina (August 10, 2023) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced four recent executive appointments...

Read More

KBI's Aaron Pilling Discusses the KBI PUREplatform Launch at BIO International 2023

KBI's PUREplatform™ is a game-changing microbial expression offering that redefines biopharmaceutical manufacturing. The platform leverages the...

Read More

KBI's Leadership Team Discusses Operational Consolidation with Selexis at BIO International 2023

The recent operational consolidation of KBI Biopharma, Inc. and Selexis SA brings a streamlined approach to support customers in rapidly accelerating...

Read More

KBI Biopharma Unveils KBI PUREplatform™, a Game-Changing Microbial Expression Offering to Redefine Biopharmaceutical Manufacturing

Platform leverages proprietary PUREcoli™ strain and cutting-edge screening packages for unmatched efficiencies and optimized production processes ...

Read More

JSR Life Sciences Announces Operational Consolidation of KBI Biopharma, Inc. and Selexis SA to Operate as one Organization, Providing Seamless Experience for Partners

KBI’s new model will enhance operational efficiencies, drive strategic clarity, and accelerate innovation for global biopharma customers Sunnyvale,...

Read More

KBI Biopharma Appoints Marykay Marchigiani as Chief Financial Officer and Sigma Mostafa, Ph.D., as Chief Scientific Officer

Durham, North Carolina (May 10, 2023) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the appointment of Marykay...

Read More

KBI Biopharma and Selexis SA Appoint J.D. Mowery as CEO

Durham, North Carolina (April 17, 2023) – KBI Biopharma, Inc. (KBI) and Selexis SA, both JSR Life Sciences companies, today announced the appointment...

Read More

KBI Biopharma, Inc. Releases Inaugural FIH Manufacturing Batch at Integrated Switzerland Facility Five Months After Opening

Milestone affirms KBI and Selexis SA’s Geneva cGMP site is operational and running successfully. GENEVA, March 21, 2023 – KBI Biopharma, Inc....

Read More

KBI Biopharma Announced as 2023 ISPE Facility of the Year Submission Finalist

KBI Biopharma is thrilled to announce that Patriot Park has been named a finalist in the 2023 ISPE Facility of the Year Awards (FOYA) in two...

Read More

Never Miss Another Update! 

Subscribe to KBI's Newsletter, The Pulse, to stay up-to-date on all the latest news, articles, and events from KBI Biopharma.